tm logo
CEBEXAN
ABANDONED SECTION 36

on 09 Feb 2024

Last Applicant/ Owned by

FARMAKEM D.O.O.

Bohova 73SI-2311 Hoce

SI

Serial Number

2159816 filed on 23rd Sep 2021

CEBEXAN

Vienna Information


26 . 4 . 26

Quadrilaterals with cutout areasQuadrilatères avec des zones découpées

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

29 . 1 . 8

BlackNoir

29 . 1 . 3

GreenVert

29 . 1 . 4

BlueBleu

Trademark usage description

pharmaceutical preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations a Read More

Classification Information


Class [005]
Pharmaceutical preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations and substances; pharmaceutical preparations and substances for use in urology; pharmaceutical preparations and substances for use in gynaecology; pharmaceutical preparations and substances for use in the field of anaesthesia; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances with analgesic properties; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances with anti-inflammatory properties; pharmaceutical preparations and substances with antipyretic properties; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for treating chemical imbalances; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating skin diseases; pharmaceutical preparations for treating wounds; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for the treatment of worms in pets; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for use in dermatology; pharmaceutical preparations against dry skin caused by pregnancy; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for activating cellular functions; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for skin moisturizing during pregnancy; pharmaceutical preparations for adapting immunity; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations to prevent stretch marks; pharmaceutical preparations for preventing skin blemishes during pregnancy; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for treating Parkinson's disease; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating sports related injuries; pharmaceutical preparations for treating cardiac arrhythmias; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the relief of insect bites; pharmaceutical preparations for human use; pharmaceutical preparations for treating eye diseases and conditions; pharmaceutical preparations for treating multiple sclerosis; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the prevention of bacteria-based diseases; pharmaceutical preparations to prevent allergies; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the prevention immune system related disorders; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the prevention of musculoskeletal diseases; pharmaceutical preparations for the prevention of diseases of the nervous system pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of endocrine system related disorders; pharmaceutical preparations for the prevention of immune system related diseases; pharmaceutical preparations for the treatment of metabolic system related diseases; pharmaceutical preparations for the prevention of the metabolic system related disorders; pharmaceutical preparations for the treatment of metabolic system related disorders; pharmaceutical preparations for the prevention of endocrine system related disorders; pharmaceutical preparations for the treatment of genitourinary system related disorders; pharmaceutical preparations for the prevention genitourinary system related disorders; pharmaceutical preparations for the prevention of metabolic system related diseases; pharmaceutical preparations for the treatment of endocrine system related diseases; pharmaceutical preparations for the prevention of respiratory system related disorders; pharmaceutical preparations for the prevention of musculoskeletal system related diseases; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for skin wounds; hair care pharmaceutical preparations; pharmaceutical preparations for treating esophagitis; pharmaceutical preparations for the prevention of ocular disorders; pharmaceutical preparations for the treatment of genitourinary system related diseases; pharmaceutical preparations for use in tissue transplantation; pharmaceutical preparations for the treatment of bacteria-based disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the prevention of bacteria-based disorders; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for use in haematology; pharmaceutical preparations for the prevention of respiratory diseases; pharmaceutical preparations for the prevention of endocrine system related diseases; pharmaceutical preparations for the prevention of eye diseases; pharmaceutical preparations for the prevention of genitourinary system related diseases; pharmaceutical preparations for ear diseases; pharmaceutical preparations for treating epilepsy; pharmaceutical preparations for treating hypoglycaemia; pharmaceutical preparations for inhalers; pharmaceutical preparations for treating epidermal problems; pharmaceutical preparations for treating metabolism disorders; pharmaceutical preparations for treating halitosis; pharmaceutical preparations for the treatment of digestive system related diseases; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of sensory organs diseases; pharmaceutical preparations for the treatment of radiation sickness symptoms; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for treating rheumatic diseases; pharmaceutical preparations for treating arthritis; pharmaceutical products for injection; pharmaceutical products for the prevention of autoimmune diseases; pharmaceutical products for the treatment of kidney diseases; pharmaceutical products for the prevention of diabetes; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of autoimmune diseases; pharmaceutical products for the treatment of kidney diseases; pharmaceutical products for smoking cessation; pharmaceutical products for inducing erection; pharmaceutical products for the treatment of erectile dysfunction; pharmaceutical products for animal skincare; pharmaceutical products against diabetes; pharmaceutical products against bacteria; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of musculoskeletal diseases; pharmaceutical preparations for the treatment of hypercholesterolemia; pharmaceutical products for treating depression; pharmaceutical products for ocular use; pharmaceutical compositions; pharmaceutical moisturizing body lotion.


Classification kind code

11

Mark Details


Serial Number

2159816

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 14
on 22nd Nov 2023
Default Notice Sent
Submitted for opposition 22
on 04th May 2023
Search Recorded
Submitted for opposition 20
on 04th May 2023
Examiner's First Report
Submitted for opposition 223
on 04th May 2023
Total Provisional Refusal
Submitted for opposition 256
on 14th Nov 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 13th Jan 2022
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 12th Jan 2022
Formalized
Submitted for opposition 1
on 12th Jan 2022
Created
Submitted for opposition 228
on 23rd Sep 2021
International Registration
Submitted for opposition 30
on 23rd Sep 2021
Filed